Our previous study analyzed the changes in the signaling molecules of the nitric oxide (NO)/soluble guanylyl cyclase (sGC)/cyclic guanosine monophosphate (cGMP) pathway in the human glioma tissues and cell lines and compared the levels of these molecules with normal controls. This evidence concerns the gene SGCB and central nervous system cancer.